The three novel variants in patients (Patient ID: CRC599, CRC600, CRC635) were found in high and moderate penetrance genes (BLM, MSH2, and PMS1) which are known to be associated with CRC so these mutations can be regarded as one of the risk factors for developing CRC. This evidence concerns the gene PMS1 and colorectal carcinoma.